Selda Sayin Kutlu

Selda Sayin Kutlu

Auto-generated profile, based on publicly available information

Selda Sayin Kutlu

Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Pamukkale University, Denizli, Turkey

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in International Journal of Infectious Diseases
Verified
Journal Article
Closed access
SKSelda Sayin Kutlu
Selda Sayin Kutlu
SSSuzan Sacar
Suzan Sacar
NCNural Cevahir
Nural Cevahir
HTHuseyin Turgut
Huseyin Turgut

1 May 2012 in American Journal of Infection Control
Verified
Journal Article
Closed access
SKSelda Sayin Kutlu
Selda Sayin Kutlu
NCNural Cevahir
Nural Cevahir
SASerife Akalin
Serife Akalin
FAFulya Akin
Fulya Akin
SCSelmin Dirgen Caylak
Selmin Dirgen Caylak
KTKoray Tekin
Koray Tekin

1 April 2012 in Journal of Hospital Infection
Verified
Journal Article
Closed access
SSS. Sayin-Kutlu
S. Sayin-Kutlu
MKM. Kutlu
M. Kutlu
Onder ErgonulOnder Ergonul
Onder Ergonul
SAS. Akalin
S. Akalin
TGT. Guven
T. Guven
Murat AkovaMurat Akova
Murat Akova

30 June 2023 in Klimik Dergisi/Klimik Journal
Verified
Journal Article
Open access
SYserap yavuz
serap yavuz
HOHasan Ozger
Hasan Ozger
ABAysun BENLİ
Aysun BENLİ
CAcan ateş
can ateş
MAMehtap Aydin
Mehtap Aydin
TOTokat
Tokat
Although brucellosis is very common in the world and Türkiye, there are no evidence-based guidelines to guide the diagnosis and treatment of the disease. This guide has been prepared by the Turkish Society of Clinical Microbiology and Infectious Diseases to provide evidence-based recommendations to physicians from different specialties interested in the diagnosis and treatment of brucellosis. The recommendations of the Clinical Practice Guide Development Guide of the Infectious Diseases Society of America (IDSA) were taken as the basis for preparing this guide. The guideline preparation group determined 20 questions considered to be important in the diagnosis and treatment of brucellosis, and the publications that could answer these questions prepared in PICO (Population/Patient [P], Intervention [I], Comparison [C], Outcome [O]) format, were searched in ULAKBİM Tr Dizin, PubMed, Cochrane databases without date restrictions. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) Working Group method was used to rank the evidence and determine the strength of the recommendations for each PICO question and for each individual outcome. Meta-analyses of comparative clinical studies were performed to answer the PICO questions. Individual participant data (IPD) meta-analyses with data obtained from case reports and case series were conducted in the absence of comparative clinical studies. It is planned to update the recommendations at regular intervals in line with the results of new studies.

8 August 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
TTTürkan Tüzün
Türkan Tüzün
SKSelda Sayin Kutlu
Selda Sayin Kutlu
MKMurat Kutlu
Murat Kutlu
İKİlknur Kaleli
İlknur Kaleli
Community-onset urinary tract infections(UTIs) caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli have increased in many parts of the world. This study aimed to determine the prevalence and risk factors for community-onset UTI caused by ESBL-producing E. coli. This prospective cohort study was conducted between January 2012 and March 2014 in cases of community-onset UTI caused by E. coli. Patients with UTI due to ESBL-producing E. coli and patients with UTI due to non-ESBL-producing E. coliwere compared to identify risk factors for ESBL-producing E. coli in the community. A total of 305 patients (116 males [46.4%]; mean age: 57.76 ± 18.06 years) were included in the study. Among these patients, 154 (50.5%) were infected with ESBL-producing E. coli. In multivariate analysis, the healthcare-associated UTI (odds ratio [OR]: 1.80; 95% confidence interval [CI]: 1.02–3.18; P = 0.041), upper urinary tract infection (OR: 3.05; 95% CI: 1.76–5.29; P < 0.0001), use of antibiotics in the preceding 6 months (OR: 2.28; 95% CI: 1.21–4.30; P = 0.011), and having two or more risk factors (OR: 4.03; 95% CI: 1.73–9.35; P = 0.001) were the significant factors associated with increased risk of community-onset UTIs due to ESBL-producing E. coli. The increasing prevalence ofESBL-producing E. coli makes it difficult to decide the empirical therapy in UTIs, especially in patients with two or more of the risk factors. A better understanding of the epidemiology and risk factors associated with community-onset UTIs due to ESBL-producing E. coli may have significant implications in decision-making for empirical antimicrobial treatment.

30 November 2011 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
SKSelda Sayin Kutlu
Selda Sayin Kutlu
ZAZafer Aybek
Zafer Aybek
KTKoray Tekin
Koray Tekin
DODemet Okke
Demet Okke
SASerife Akalin
Serife Akalin
MDMelek Demir
Melek Demir
Introduction: Duration of treatment of asymptomatic bacteriuria for patients undergoing urologic surgical procedures is undetermined. We compared the efficacy of long- versus short-course antimicrobial treatment in patients with asymptomatic bacteriuria undergoing urologic surgical procedures. Methodology: Patients were divided into two groups according to duration of antimicrobial treatment. Group A patients received a single dose of an appropriate antibiotic, determined by antimicrobial sensitivity testing, 30 to 60 minutes before the surgical procedure. If a urinary catheter was placed postoperatively, a second dose was given following the recommended dose interval. Group B patients received antimicrobial treatment prior to surgery at least until patient urine became sterile. All patients were monitored for signs and symptoms of septicemia following surgical procedures. Results: None of the patients enrolled in the study developed infectious complications such as sepsis or upper urinary tract infection. In group A, 31 patients were treated with antimicrobials before 39 urological procedures. In group B, the mean treatment time for 28 patients before 30 urological procedures was 8.03 ± 3.86 days. There were also significant differences in length of stay and the cost of antimicrobial therapy between the groups (P < 0.0001). Isolation of an increased number of resistant microorganisms was associated with long course therapy in group B. Conclusions: Short course therapy protocol may be a practical, simple approach for antibiotic use; it decreases hospital stays, eliminates delayed procedure times, lowers the economic cost of antimicrobials and lessens the chance of superinfection with and spread of antimicrobial resistant microorganisms.